PF-06273588
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-06273588, covering 2011-09-09 to 2011-09-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study To Investigate The Elimination Of PF-06273588 From The Body Following A Single Low Dose. [Phase 1]